SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001802768-24-000010
Filing Date
2024-02-15
Accepted
2024-02-15 07:33:43
Documents
30
Period of Report
2024-02-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rprx-20240215.htm   iXBRL 8-K 24521
2 EX-99.1 rprx-20231231rpplcpressx.htm EX-99.1 44214
6 rprx-20231231rpplcpressx001.jpg GRAPHIC 188280
7 rprx-20231231rpplcpressx002.jpg GRAPHIC 161519
8 rprx-20231231rpplcpressx003.jpg GRAPHIC 147640
9 rprx-20231231rpplcpressx004.jpg GRAPHIC 159579
10 rprx-20231231rpplcpressx005.jpg GRAPHIC 177651
11 rprx-20231231rpplcpressx006.jpg GRAPHIC 167405
12 rprx-20231231rpplcpressx007.jpg GRAPHIC 209946
13 rprx-20231231rpplcpressx008.jpg GRAPHIC 177572
14 rprx-20231231rpplcpressx009.jpg GRAPHIC 102492
15 rprx-20231231rpplcpressx010.jpg GRAPHIC 55836
16 rprx-20231231rpplcpressx011.jpg GRAPHIC 146282
17 rprx-20231231rpplcpressx012.jpg GRAPHIC 85038
18 rprx-20231231rpplcpressx013.jpg GRAPHIC 72237
19 rprx-20231231rpplcpressx014.jpg GRAPHIC 73128
20 rprx-20231231rpplcpressx015.jpg GRAPHIC 139984
  Complete submission text file 0001802768-24-000010.txt   3055991

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20240215.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20240215_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20240215_pre.xml EX-101.PRE 12524
31 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20240215_htm.xml XML 2725
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 24642107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)